Figure 2

Comparison of gp100 vaccination protocols performed either in syngeneic or xenogeneic setting. (A) Comparative analysis of the different gp100 vaccination protocols in a xenogeneic setting. B16F10 melanoma growth curves in differently treated and control mice (*p = 0.05; **p = 0.01); (B) Elispot analysis of frequency of IFNγ-secreting splenocytes from differently treated and control mice in a xenogeneic setting; (C) Comparison of gp100 vaccination protocols performed in syngeneic (light grey columns) or xenogeneic (dark grey columns) settings. Data refer to the assessment performed after 21 days from B16F10 melanoma challenge when mice were sacrificed.